Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Biotechnology 60 5.1%
Current Price (07/17) $67.04
CAPS Rating (Rate this stock on CAPS) Foolcaps 5
Expected Income Statement
Current Sales 22,061.0
Sales Growth Forecast 0.2%
Net Profit Margin 35.8%
Projected Shares Outstanding 1,278.00
EPS - Five year Forecast $6.24
Average P/E Ratio 12.0
Projected Average Price $74.85
Price Appreciation (Annualized) 2.2%
Annual Dividend Yield 2.9%
Projected Annual Return 5.1%
Quality
Financial Strength 94 23.6
EPS Stability 45 11.2
Industry Sales Growth Rate 16.5% 0.1
Industry Net Profit Margin 29.0% 15.4
Calculated Quality Rating 50.4
Fool CAPS

Total Players

3489 Outperforms
90 Underperforms
 

All-Stars (698)

684 Outperforms (98%)
14 Underperforms
 
Fundamental Data Updated: 07/12/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 15.1%
BIIB 79 15.7%
BSTC 80 15.3%
REGN 80 22.7%
RGEN 71 15.8%

Top In Healthcare

Ticker Quality PAR
ALGN 99 21.4%
ABMD 82 19.1%
JAZZ 94 15.1%
CMD 92 14.1%
ABBV 87 15.4%